Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 15, Issue 11, Pages 2921-2930Publisher
WILEY-BLACKWELL
DOI: 10.1111/ajt.13347
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research
- KRESCENT fellowship award
- University of Manitoba Department of Internal Medicine
- KRESCENT new investigator award
- Manitoba Medical Services Foundation-Dr. F.W. Duval Clinical Research Professorship
Ask authors/readers for more resources
Understanding rates and determinants of clinical pathologic progression for recipients with de novo donor-specific antibody (dnDSA), especially subclinical dnDSA, may identify surrogate endpoints and inform clinical trial design. A consecutive cohort of 508 renal transplant recipients (n=64 with dnDSA) was studied. Recipients (n=388) without dnDSA or dysfunction had an eGFR decline of -0.65mL/min/1.73m(2)/year. In recipients with dnDSA, the rate eGFR decline was significantly increased prior to dnDSA onset (-2.89 vs. -0.65mL/min/1.73m(2)/year, p<0.0001) and accelerated post-dnDSA (-3.63 vs. -2.89mL/min/1.73m(2)/year, p<0.0001), suggesting that dnDSA is both a marker and contributor to ongoing alloimmunity. Time to 50% post-dnDSA graft loss was longer in recipients with subclinical versus a clinical dnDSA phenotype (8.3 vs. 3.3 years, p<0.0001). Analysis of 1091 allograft biopsies found that dnDSA and time independently predicted chronic glomerulopathy (cg), but not interstitial fibrosis and tubular atrophy (IFTA). Early T cell-mediated rejection, nonadherence, and time were multivariate predictors of IFTA. Independent risk factors for post-dnDSA graft survival available prior to, or at the time of, dnDSA detection were delayed graft function, nonadherence, dnDSA mean fluorescence intensity sum score, tubulitis, and cg. Ultimately, dnDSA is part of a continuum of mixed alloimmune-mediated injury, which requires solutions targeting T and B cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available